600201.SH
生物股份
SSE · Healthcare · Biotechnology · CN
CNY 12.43
−1.74%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- CNY 0.08
- Revenue estimate
- CNY 263.1M
Latest reported
- Last report date
- Aug 4, 2026
- EPS actual
- CNY 0.02
- EPS estimate
- CNY 0.20
- Revenue actual
- CNY 407.3M
- Revenue estimate
- CNY 509.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -90.1%
- Revenue beats (12Q)
- 0
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026